Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health systemTyler C Chervo, Eric P Elkin, Joshua R Nugent, et al.
Plos One|June 20, 2024
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health systemTyler C Chervo, Eric P Elkin, Joshua R Nugent, et al.
Plos One|March 7, 2009
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 updateDiane E Bennett, Ricardo J Camacho, Dan Otelea, et al.
Plos One|July 29, 2017
Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretationRoger Paredes, Philip L Tzou, Gert van Zyl, et al.
Plos One|January 30, 2014
Comparable long-term efficacy of Lopinavir/Ritonavir and similar drug-resistance profiles in different HIV-1 subtypesZehava Grossman, Jonathan M Schapiro, Itzchak Levy, et al.
The Lancet. Infectious Diseases|March 25, 2011
European guidelines on the clinical management of HIV-1 tropism testingL P R Vandekerckhove, A M J Wensing, R Kaiser, et al.
Viruses|June 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined ScenariosRobert W Shafer, Kaiming Tao, Tom Loosli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2023
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic FailureChloe Orkin, Jonathan M Schapiro, Carlo F Perno, et al.
AIDS (London, England)|March 17, 2021
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysisAmy G Cutrell, Jonathan M Schapiro, Carlo F Perno, et al.
Nature Immunology|November 10, 2020
Proinflammatory IgG Fc structures in patients with severe COVID-19Saborni Chakraborty, Joseph Gonzalez, Karlie Edwards, et al.
Pageof 14